These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 28452427)
1. Results of an innovative bulking agent in patients with stress urinary incontinence who are not optimal candidates for mid-urethral sling surgery. Kowalik CR; Casteleijn FM; van Eijndhoven HWF; Zwolsman SE; Roovers JWR Neurourol Urodyn; 2018 Jan; 37(1):339-345. PubMed ID: 28452427 [TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of urethral bulking polydimethylsiloxane-Urolastic® compared with mid-urethral sling surgery for stress urinary incontinence: A two-arm cohort study. Casteleijn FM; de Vries AM; Tu LM; Heesakkers JPFA; Latul Y; Kowalik CR; van Eijndhoven HWF; van Eekelen R; Roovers JWR BJOG; 2023 May; 130(6):674-683. PubMed ID: 36660885 [TBL] [Abstract][Full Text] [Related]
3. Sexual Function Following Treatment for Stress Urinary Incontinence With Bulk Injection Therapy and Mid-Urethral Sling Surgery. Latul YP; Casteleijn FM; Zwolsman SE; Roovers JWR J Sex Med; 2022 Jul; 19(7):1116-1123. PubMed ID: 35568668 [TBL] [Abstract][Full Text] [Related]
4. Urethral bulking agents versus other surgical procedures for the treatment of female stress urinary incontinence: a systematic review and meta-analysis. Leone Roberti Maggiore U; Bogani G; Meschia M; Sorice P; Braga A; Salvatore S; Ghezzi F; Serati M Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():48-54. PubMed ID: 25855326 [TBL] [Abstract][Full Text] [Related]
5. Can Urethral Bulking Agents Salvage Failed Slings? Dray EV; Hall M; Covalschi D; Cameron AP Urology; 2019 Feb; 124():78-82. PubMed ID: 30412703 [TBL] [Abstract][Full Text] [Related]
7. Nonabsorbable urethral bulking agent - clinical effectiveness and late complications rates in the treatment of recurrent stress urinary incontinence after 2 years of follow-up. Futyma K; Nowakowski Ł; Gałczyński K; Miotła P; Rechberger T Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():68-72. PubMed ID: 27825030 [TBL] [Abstract][Full Text] [Related]
8. Outcomes of Macroplastique injections for stress urinary incontinence after suburethral sling removal. Rodríguez D; Carroll T; Alhalabi F; Carmel M; Zimmern PE Neurourol Urodyn; 2020 Mar; 39(3):994-1001. PubMed ID: 32068306 [TBL] [Abstract][Full Text] [Related]
9. Macroplastique for women with stress urinary incontinence secondary to intrinsic sphincter deficiency. Carroll TF; Christie A; Foreman M; Khatri G; Zimmern PE Int Braz J Urol; 2019; 45(5):989-998. PubMed ID: 31626522 [TBL] [Abstract][Full Text] [Related]
10. How cure rates drive patients' preference for urethral bulking agent or mid-urethral sling surgery as therapy for stress urinary incontinence. Casteleijn FM; Enklaar RA; El Bouyahyaoui I; Jeffery S; Zwolsman SE; Roovers JWR Neurourol Urodyn; 2019 Jun; 38(5):1384-1391. PubMed ID: 30989703 [TBL] [Abstract][Full Text] [Related]
11. [Bladder injury during sling operation in the treatment of SUI--review of literature and case report]. Gałczyński K; Futyma K; Bar K; Rechberger T Ginekol Pol; 2012 Oct; 83(10):784-8. PubMed ID: 23383566 [TBL] [Abstract][Full Text] [Related]
12. Prospective randomized comparison of the transobturator mid-urethral sling with the single-incision sling among women with stress urinary incontinence: 1-year follow-up study. Jurakova M; Huser M; Belkov I; Janku P; Hudecek R; Stourac P; Jarkovsky J; Ventruba P Int Urogynecol J; 2016 May; 27(5):791-6. PubMed ID: 26630947 [TBL] [Abstract][Full Text] [Related]
13. An Open Multicenter Study of Clinical Efficacy and Safety of Urolastic, an Injectable Implant for the Treatment of Stress Urinary Incontinence: One-Year Observation. Futyma K; Miotła P; Gałczyński K; Baranowski W; Doniec J; Wodzisławska A; Jóźwik M; Oniszczuk M; Rechberger T Biomed Res Int; 2015; 2015():851823. PubMed ID: 26106616 [TBL] [Abstract][Full Text] [Related]
14. Patients' perspectives on urethral bulk injection therapy and mid-urethral sling surgery for stress urinary incontinence. Casteleijn FM; Zwolsman SE; Kowalik CR; Roovers JPWR Int Urogynecol J; 2018 Sep; 29(9):1249-1257. PubMed ID: 29675556 [TBL] [Abstract][Full Text] [Related]
15. Does the Polydimethylsiloxane Urethral Injection (Macroplastique Serati M; Braga A; Scancarello C; De Rosa A; Frigerio M; Baruch Y; Torella M; Salvatore S; Ruffolo AF Medicina (Kaunas); 2023 Mar; 59(3):. PubMed ID: 36984580 [No Abstract] [Full Text] [Related]
16. Bulking agents: an analysis of 500 cases and review of the literature. Mohr S; Siegenthaler M; Mueller MD; Kuhn A Int Urogynecol J; 2013 Feb; 24(2):241-7. PubMed ID: 22707004 [TBL] [Abstract][Full Text] [Related]
17. Urolastic®, a new bulking agent for treatment of stress urinary incontinence: a systematic review and meta-analysis. Capobianco G; Azzena A; Saderi L; Dessole F; Dessole S; Sotgiu G Int Urogynecol J; 2018 Sep; 29(9):1239-1247. PubMed ID: 29934769 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of polydimethylsiloxane injection (Macroplastique Serati M; Soligo M; Braga A; Cantaluppi S; Coluccia AC; Di Dedda MC; Salvatore S; Cetin I; Ghezzi F; BJU Int; 2019 Feb; 123(2):353-359. PubMed ID: 30253026 [TBL] [Abstract][Full Text] [Related]
19. Mixed urinary incontinence: A prospective study on the effect of trans-obturator mid-urethral sling. Natale F; Illiano E; La Penna C; Balsamo R; Costantini E Eur J Obstet Gynecol Reprod Biol; 2018 Feb; 221():64-69. PubMed ID: 29248808 [TBL] [Abstract][Full Text] [Related]
20. Adjustable transobturator sling for the treatment of primary stress urinary incontinence. Shkarupa D; Kubin N; Staroseltseva O; Shapovalova E Int Urogynecol J; 2018 Sep; 29(9):1341-1347. PubMed ID: 29177542 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]